Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1500648800HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

FDA raises cognitive concerns with PCSK9s; Amgen, Sanofi, Regeneron hit

08.03.2014 / Scripintelligence

And it did so most harshly to Tarrytown, New York-based Regeneron, whose shares tumbled 10.1% on 7 March, or $34.25, before closing at $328.11, down $10.34, or 3.06%.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: